HomeInsightsStock Comparison

Mangalam Global Enterprise Ltd vs Q Line Biotech Ltd Stock Comparison

Mangalam Global Enterprise Ltd vs Q Line Biotech Ltd Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

  • The Latest Trading Price of Mangalam Global Enterprise Ltd is ₹ 17.41 as of 30 Oct 15:30 . The P/E Ratio of Mangalam Global Enterprise Ltd changed from 19.8 on March 2021 to 8.1 on March 2026 . This represents a CAGR of -13.84% over 6 yearsThe P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Mangalam Global Enterprise Ltd changed from ₹ 574.47 crore on March 2021 to ₹ 365.81 crore on March 2026 . This represents a CAGR of -7.25% over 6 yearsThe Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Mangalam Global Enterprise Ltd for the Sep '26 is ₹ 983.13 crore as compare to the Jun '26 revenue of ₹ 955.33 crore. This represent the growth of 2.91% The revenue of Q-Line Biotech Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Mangalam Global Enterprise Ltd for the Sep '26 is ₹ 23.1 crore as compare to the Jun '26 ebitda of ₹ 21.7 crore. This represent the growth of 6.45% The ebitda of Q-Line Biotech Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Mangalam Global Enterprise Ltd changed from ₹ 6.01 crore to ₹ 9.25 crore over 10 quarters. This represents a CAGR of 18.82% The net profit of Q-Line Biotech Ltd changed from ₹ 17.38 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The Dividend Payout of Mangalam Global Enterprise Ltd changed from 47.43 % on March 2021 to 0.8 % on March 2026 . This represents a CAGR of -49.36% over 6 yearsThe Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Mangalam Global Enterprise Ltd

  • Mangalam Global Enterprise Limited was originally incorporated as a Private Limited Company with the name 'Hindprakash Colourchem Private Limited' on September 27, 2010.
  • Further, the name of the Company was changed to 'Mangalam Global Enterprise Private Limited' and a fresh Certificate of Incorporation dated July 31, 2014 was issued by Registrar of Companies, Ahmedabad.
  • Subsequently, the Company converted into a Public Limited Company and the name was changed to 'Mangalam Global Enterprise Limited' on September 30, 2019. The Company belongs to Ahmedabad based Mangalam Group of Companies set up by Mangal Family and led by the vision of Mr. Vipin Prakash Mangal.
  • The Company is mainly engaged into: Manufacturing, trading and import of Edible Oil/ Non-edible oil and Agricultural Products i.e.

About Q-Line Biotech Ltd

  • Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
  • Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
  • Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

FAQs for the comparison of Mangalam Global Enterprise Ltd and Q-Line Biotech Ltd

Which company has a larger market capitalization, Mangalam Global Enterprise Ltd or Q-Line Biotech Ltd?

Market cap of Mangalam Global Enterprise Ltd is 573 Cr while Market cap of Q-Line Biotech Ltd is 1,196 Cr

What are the key factors driving the stock performance of Mangalam Global Enterprise Ltd and Q-Line Biotech Ltd?

The stock performance of Mangalam Global Enterprise Ltd and Q-Line Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mangalam Global Enterprise Ltd and Q-Line Biotech Ltd?

As of October 31, 2026, the Mangalam Global Enterprise Ltd stock price is INR ₹17.41. On the other hand, Q-Line Biotech Ltd stock price is INR ₹512.75.

How do dividend payouts of Mangalam Global Enterprise Ltd and Q-Line Biotech Ltd compare?

To compare the dividend payouts of Mangalam Global Enterprise Ltd and Q-Line Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions